FBRX — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

6.03

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

0.44

EPS Last/This Y

0.24

EPS This/Next Y

0.26

Price

26.29

Target Price

63.75

Analyst Recom

Performance Q

Upside

-360.3%

Beta

3.24

Ticker: FBRX

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	FBRX	27.72	0.21	999.99	374
2026-03-10	FBRX	28.55	0.21	999.99	374
2026-03-11	FBRX	27.33	0.21	999.99	374
2026-03-12	FBRX	27.08	0.21	999.99	374
2026-03-13	FBRX	27.12	0.21	999.99	374
2026-03-17	FBRX	26.42	0.21	0.00	375
2026-03-18	FBRX	25	0.05	999.99	1430
2026-03-20	FBRX	23.23	0.05	0.00	1432
2026-03-25	FBRX	26.35	0.05	999.99	1418
2026-03-26	FBRX	27.11	0.12	0.00	1518
2026-03-27	FBRX	25.65	0.12	999.99	1528
2026-03-30	FBRX	26.3	0.12	999.99	1528
2026-03-31	FBRX	25.93	0.12	999.99	1528
2026-04-01	FBRX	25.01	0.20	0.00	1628
2026-04-06	FBRX	26.34	0.20	0.00	1630
2026-04-07	FBRX	26.28	0.20	0.00	1630
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	FBRX	27.90	-	-	-4.32
2026-03-10	FBRX	28.42	-	-	-4.32
2026-03-11	FBRX	27.00	-	-	-4.32
2026-03-12	FBRX	27.16	-	-	-4.32
2026-03-13	FBRX	26.67	-	-	-4.32
2026-03-17	FBRX	26.27	-	-	-4.32
2026-03-18	FBRX	24.88	-	-	-4.32
2026-03-19	FBRX	24.59	-	-	-4.32
2026-03-20	FBRX	22.88	-	-	-4.32
2026-03-23	FBRX	25.65	-	-	-4.32
2026-03-24	FBRX	25.57	-	-	-4.32
2026-03-25	FBRX	26.59	-	-	-4.32
2026-03-26	FBRX	27.23	-	-	-4.32
2026-03-27	FBRX	25.69	-	-	-4.32
2026-03-30	FBRX	26.16	-	-	-4.32
2026-03-31	FBRX	25.83	-	-	-4.32
2026-04-01	FBRX	24.92	-	-	-4.32
2026-04-02	FBRX	25.56	-	-	-4.32
2026-04-06	FBRX	26.49	14.6	-	-4.47
2026-04-07	FBRX	26.29	14.6	-	-4.47
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	FBRX	0.59	5.37	7.18
2026-03-10	FBRX	0.59	5.37	7.18
2026-03-11	FBRX	0.59	5.37	6.54
2026-03-12	FBRX	0.59	5.37	6.54
2026-03-13	FBRX	0.59	5.37	6.54
2026-03-18	FBRX	0.59	5.42	6.54
2026-03-19	FBRX	0.59	5.42	6.54
2026-03-20	FBRX	0.59	5.42	6.54
2026-03-23	FBRX	0.59	5.43	6.54
2026-03-24	FBRX	0.59	5.43	6.54
2026-03-25	FBRX	0.59	5.43	6.68
2026-03-26	FBRX	0.59	5.43	6.68
2026-03-27	FBRX	0.59	5.43	6.68
2026-03-30	FBRX	0.59	5.45	6.68
2026-03-31	FBRX	0.59	5.45	6.68
2026-04-01	FBRX	0.59	5.45	6.68
2026-04-02	FBRX	0.59	5.45	6.68
2026-04-06	FBRX	0.54	4.84	6.03
2026-04-07	FBRX	0.54	4.84	6.03
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-1.45

Avg. EPS Est. Current Quarter

-1.18

Avg. EPS Est. Next Quarter

-1.01

Insider Transactions

0.54

Institutional Transactions

4.84

Beta

3.24

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.6

Max Drawdown 5-Year %

-99.6

Target Price

63.75

P/E

Forward P/E

PEG

P/S

P/B

5.56

P/Free Cash Flow

EPS

-5.24

Average EPS Est. Cur. Y

-4.47

EPS Next Y. (Est.)

-4.21

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.83

Return on Equity vs Sector %

-141.2

Return on Equity vs Industry %

-124.7

EPS 1 7Days Diff

-0.9

EPS 1 30Days Diff

-0.89

EBIT Estimation

◆ FBRX Healthcare

$26.17

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

19/25

Volume

7/15

Valuation

9/20

TP/AR

2/10

Options

7/10

RSI

47.2

Range 1M

53.5%

Sup Dist

1.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

7/30

Estimates

0/20

Inst/Vol

7/15

Options

8/10

EPS Yr

7.9%

EPS NY

0.4%

52W%

70.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +143.6% upside

Quality

2/30

Valuation

16/30

Growth

2/25

Stability

9/10

LT Trend

3/5

Upside

+143.6%

Quality

Forte Biosciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees:

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

FBRX

Latest News

—

Caricamento notizie per FBRX…

stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today

news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance

stock history FBRX – Forte Biosciences Inc invest stock market

stock prices FBRX premarket after hours

ticker FBRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: FBRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y